Nimbus Therapeutics

Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical-stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. Nimbus Therapeutics designs highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer, and immune-inflammatory disorders.

Nimbus Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $68.8B in funding across 108 round(s). With a team of 51-100 employees, Nimbus Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Nimbus Therapeutics, raised $1.5M. Discover more about their projects, partnerships, and impact on our platform.